Sort
8,912 grants matching “sars cov 2”
FORUM ON MEDICAL AND PUBLIC HEALTH PREPAREDNESS FOR DISASTERS AND EMERGENCIES AND ACTION COLLABORATIVE ON DISASTERS/PUBLIC HEALTH EMERGENCY RESEARCH
$40,000Robert Day · National Academy Of Sciences · N01 · FY2023 · OD
2022 Angiotensin GRC/GRS
$40,000Minolfa C Prieto · Gordon Research Conferences · R13 · FY2022 · HL
FDA Vet-LIRN Capacity-Building of Ohio ADDL to support rapid testing for COVID-19
$40,000Melanie Prarat · Ohio State Department Of Agriculture · U18 · FY2023 · FD
FASEB SRC: The Lung Epithelium Conference: In Health and Disease
$40,000Jonathan Andrew Kropski · Federation Of Amer Soc For Exper Biology · R13 · FY2022 · HL
Development of PD-L1 Proteolysis-Targeting Chimeras (PROTACs): An Innovative Cancer Drug Discovery Route
$39,917Demonta Coleman · Texas A&M University · F31 · FY2025 · CA
Identifying individual and community factors associated with high COVID-19 incidence and mortality rates among people with HIV.
$39,863Tendai Nomhle Rumbidzai Gwanzura · Florida International University · F31 · FY2024 · MD
Building UI VDL COVID-19 test capacity: evaluating sample pooling for SARS-CoV-2 testing in animals
$39,650Leyi Wang · University Of Illinois At Urbana-Champaign · U18 · FY2023 · FD
Building UI VDL COVID-19 test capacity: evaluating a SARS-CoV-2 LAMP assay for animal samples
$39,650Leyi Wang · University Of Illinois At Urbana-Champaign · U18 · FY2023 · FD
NIAID DCR OPERATIONAL TASK ORDER FOR DMID COVAIL SUPPORT
$39,644Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV Supplement
$39,400Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2021 · HL
Development of PD-L1 Proteolysis-Targeting Chimeras (PROTACs): An Innovative Cancer Drug Discovery Route
$39,353Demonta Coleman · Texas A&M University · F31 · FY2024 · CA
Evolution, transmission, and clinical impacts of SARS-CoV-2 variants among urban and rural populations
$39,032Cynthia Y Tang · University Of Missouri-Columbia · F30 · FY2022 · AI
Impacts of SARS-CoV-2 Infection and Age on Musculoskeletal Health
$39,019Olatundun Dupe Awosanya · Indiana University Indianapolis · F31 · FY2022 · AG
Determining Tropism and Mechanisms of Ebola Virus Entry in Placental Tissues
$38,960Hanora Anne Marie Van Ert · University Of Iowa · F30 · FY2023 · AI
Evaluation of Oropharyngeal responses to SARS-CoV-2
$38,953Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
The Pathogenic Role of IL-33 in the SARS-CoV-2-Infected Lung
$38,922Claire Fleming · University Of Virginia · F31 · FY2025 · HL
Screening for regulators of SARS CoV-2 infection and inflammation
$38,806Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Exploring the role of hyper-phagocytic microglia and SYK signaling in the aged hippocampus during COVID-19
$38,747Nick Natale · University Of Virginia · F31 · FY2025 · NS
Defining the COVID19 risk in the Greater Mekong Subregion
$38,687Jessica Manning · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Studies on the SARS-CoV-2 Main Protease Dimerization Mechanism
$38,674Renee Delgado · University Of Texas Hlth Science Center · F31 · FY2025 · AI
Recombinant Engineering of SARS-CoV-2 Spike and N proteins
$38,570David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Yeast Based Assays for Chemical Screens Against SARS-CoV Targets
$38,500Daniel A Engel · University Of Virginia · R21 · FY2010 · NS
Countermeasures against COVID-19
$38,451Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Harnessing the power of extracellular matrix to treat COVID-19 ARDS
$38,344Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Identifying individual and community factors associated with high COVID-19 incidence and mortality rates among people with HIV.
$38,255Tendai Nomhle Rumbidzai Gwanzura · Florida International University · F31 · FY2023 · MD